NORTH CAROLINA NEONATAL
PHARMACOLOGY CERTIFICATION EXAM
2026 | RNC-NIC PRACTICE QUESTIONS &
VERIFIED ANSWERS | COMPREHENSIVE
STUDY GUIDE
• Comprehensive question practice exam designed to mirror the RNC-NIC Neonatal
Pharmacology Certification—covers all major pharmacological domains with
detailed clinical rationales for exam mastery.
• Study systematically through this guide by working 20-30 questions daily, focusing
on rationales to understand drug mechanisms, dosing, and clinical applications
specific to neonatal patient care.
1. When administering medications to a neonate with immature liver
function, which pharmacokinetic parameter is most significantly affected?
A) Absorption rate
B) Volume of distribution
C) Metabolism and drug clearance
D) Renal excretion primarily
E) Half-life remains unchanged
CORRECT ANSWER: C) Metabolism and drug clearance
RATIONALE: Neonates, particularly preterm infants, have immature hepatic enzyme
systems (Phase I and II metabolism). This results in significantly prolonged drug
half-lives and reduced clearance of drugs that depend on hepatic metabolism.
While renal excretion is also immature, many drugs rely primarily on hepatic
metabolism in neonates, making this the most critical pharmacokinetic parameter
affected. Absorption and volume of distribution may be altered but are secondary
concerns compared to severely impaired metabolism.
,2. A 3-day-old term infant receiving gentamicin for suspected sepsis has a
serum creatinine of 1.2 mg/dL. How should the dosing interval be adjusted?
A) No adjustment needed; use standard neonatal dosing
B) Increase the dose and maintain standard intervals
C) Extend the dosing interval to every 24-36 hours
D) Switch to cephalosporin immediately
E) Reduce dose by 50% with standard intervals
CORRECT ANSWER: C) Extend the dosing interval to every 24-36 hours
RATIONALE: In neonates with elevated creatinine, renal function is compromised.
Aminoglycosides like gentamicin are renally excreted and accumulate with reduced
clearance. Extended-interval dosing (24-36 hours based on gestational age and
renal function) prevents ototoxicity and nephrotoxicity. The elevated creatinine
indicates reduced glomerular filtration rate, necessitating interval extension rather
than dose reduction alone. This approach maintains efficacy while reducing toxicity
risk.
3. Which of the following medications is safest for pain management in a 2-
week-old neonate with respiratory support?
A) Ibuprofen for sustained analgesia
B) Acetaminophen every 6 hours
C) Morphine with careful monitoring
D) Aspirin for mild to moderate pain
E) Ketorolac for acute pain
CORRECT ANSWER: C) Morphine with careful monitoring
RATIONALE: Morphine is the gold standard opioid for neonatal analgesia when
used with careful monitoring of respiratory status, heart rate, and blood pressure.
Ibuprofen increases risk of patent ductus arteriosus closure and is contraindicated
,in the first weeks of life. Acetaminophen alone is insufficient for moderate to severe
pain. Aspirin carries risk of Reye syndrome in infants. Ketorolac is an NSAID
contraindicated in neonates due to renal and GI concerns. Morphine's safety
profile, when titrated and monitored appropriately, makes it the preferred choice
for neonatal analgesia.
4. A premature infant at 28 weeks gestation requires surfactant replacement.
Which medication would be considered first-line therapy?
A) Poractant alfa (Curosurf)
B) Doxapram for respiratory stimulation
C) Methylxanthines alone
D) Positive pressure ventilation without surfactant
E) Amoxicillin for infection prevention
CORRECT ANSWER: A) Poractant alfa (Curosurf)
RATIONALE: Poractant alfa and other exogenous surfactants (beractant, calfactant)
are first-line medications for respiratory distress syndrome in preterm infants.
These surfactants replace deficient endogenous pulmonary surfactant, reducing
surface tension and improving lung compliance and oxygenation. Poractant alfa is
often preferred due to its higher phospholipid content. Doxapram is a respiratory
stimulant used for apnea of prematurity, not RDS. Methylxanthines and antibiotics
are adjunctive therapies. Surfactant replacement is essential and standard of care.
5. Which antibiotic combination is standard empiric therapy for suspected
neonatal sepsis?
A) Gentamicin and cefotaxime
B) Ampicillin, gentamicin, and cefotaxime
C) Ampicillin and gentamicin
D) Cephalexin and tobramycin
, E) Penicillin G and chloramphenicol
CORRECT ANSWER: C) Ampicillin and gentamicin
RATIONALE: Ampicillin and gentamicin represent first-line empiric therapy for early-
onset sepsis in neonates. Ampicillin covers Group B Streptococcus and Listeria
monocytogenes (gram-positive organisms), while gentamicin covers aerobic gram-
negative organisms including E. coli. This combination provides synergistic coverage
for most organisms causing early-onset neonatal sepsis. Cefotaxime is added for
late-onset sepsis or when meningitis is suspected. Chloramphenicol has fallen out
of favor due to toxicity. Cephalosporins alone are inadequate for initial empiric
coverage.
6. A neonate is receiving indomethacin for patent ductus arteriosus closure.
Which laboratory value requires closest monitoring?
A) Serum glucose
B) Serum creatinine and urine output
C) Hemoglobin level
D) Platelet count only
E) Liver enzymes exclusively
CORRECT ANSWER: B) Serum creatinine and urine output
RATIONALE: Indomethacin, a nonsteroidal anti-inflammatory drug used for PDA
closure, significantly reduces renal perfusion through inhibition of renal
prostaglandin synthesis. This can precipitate acute kidney injury, manifesting as
elevated creatinine and decreased urine output. Close monitoring of renal function
(creatinine, BUN, urine output) is essential before each dose. While platelet count
can decrease and GI bleeding may occur, renal complications are the most clinically
significant adverse effect requiring intensive monitoring during indomethacin
therapy.
PHARMACOLOGY CERTIFICATION EXAM
2026 | RNC-NIC PRACTICE QUESTIONS &
VERIFIED ANSWERS | COMPREHENSIVE
STUDY GUIDE
• Comprehensive question practice exam designed to mirror the RNC-NIC Neonatal
Pharmacology Certification—covers all major pharmacological domains with
detailed clinical rationales for exam mastery.
• Study systematically through this guide by working 20-30 questions daily, focusing
on rationales to understand drug mechanisms, dosing, and clinical applications
specific to neonatal patient care.
1. When administering medications to a neonate with immature liver
function, which pharmacokinetic parameter is most significantly affected?
A) Absorption rate
B) Volume of distribution
C) Metabolism and drug clearance
D) Renal excretion primarily
E) Half-life remains unchanged
CORRECT ANSWER: C) Metabolism and drug clearance
RATIONALE: Neonates, particularly preterm infants, have immature hepatic enzyme
systems (Phase I and II metabolism). This results in significantly prolonged drug
half-lives and reduced clearance of drugs that depend on hepatic metabolism.
While renal excretion is also immature, many drugs rely primarily on hepatic
metabolism in neonates, making this the most critical pharmacokinetic parameter
affected. Absorption and volume of distribution may be altered but are secondary
concerns compared to severely impaired metabolism.
,2. A 3-day-old term infant receiving gentamicin for suspected sepsis has a
serum creatinine of 1.2 mg/dL. How should the dosing interval be adjusted?
A) No adjustment needed; use standard neonatal dosing
B) Increase the dose and maintain standard intervals
C) Extend the dosing interval to every 24-36 hours
D) Switch to cephalosporin immediately
E) Reduce dose by 50% with standard intervals
CORRECT ANSWER: C) Extend the dosing interval to every 24-36 hours
RATIONALE: In neonates with elevated creatinine, renal function is compromised.
Aminoglycosides like gentamicin are renally excreted and accumulate with reduced
clearance. Extended-interval dosing (24-36 hours based on gestational age and
renal function) prevents ototoxicity and nephrotoxicity. The elevated creatinine
indicates reduced glomerular filtration rate, necessitating interval extension rather
than dose reduction alone. This approach maintains efficacy while reducing toxicity
risk.
3. Which of the following medications is safest for pain management in a 2-
week-old neonate with respiratory support?
A) Ibuprofen for sustained analgesia
B) Acetaminophen every 6 hours
C) Morphine with careful monitoring
D) Aspirin for mild to moderate pain
E) Ketorolac for acute pain
CORRECT ANSWER: C) Morphine with careful monitoring
RATIONALE: Morphine is the gold standard opioid for neonatal analgesia when
used with careful monitoring of respiratory status, heart rate, and blood pressure.
Ibuprofen increases risk of patent ductus arteriosus closure and is contraindicated
,in the first weeks of life. Acetaminophen alone is insufficient for moderate to severe
pain. Aspirin carries risk of Reye syndrome in infants. Ketorolac is an NSAID
contraindicated in neonates due to renal and GI concerns. Morphine's safety
profile, when titrated and monitored appropriately, makes it the preferred choice
for neonatal analgesia.
4. A premature infant at 28 weeks gestation requires surfactant replacement.
Which medication would be considered first-line therapy?
A) Poractant alfa (Curosurf)
B) Doxapram for respiratory stimulation
C) Methylxanthines alone
D) Positive pressure ventilation without surfactant
E) Amoxicillin for infection prevention
CORRECT ANSWER: A) Poractant alfa (Curosurf)
RATIONALE: Poractant alfa and other exogenous surfactants (beractant, calfactant)
are first-line medications for respiratory distress syndrome in preterm infants.
These surfactants replace deficient endogenous pulmonary surfactant, reducing
surface tension and improving lung compliance and oxygenation. Poractant alfa is
often preferred due to its higher phospholipid content. Doxapram is a respiratory
stimulant used for apnea of prematurity, not RDS. Methylxanthines and antibiotics
are adjunctive therapies. Surfactant replacement is essential and standard of care.
5. Which antibiotic combination is standard empiric therapy for suspected
neonatal sepsis?
A) Gentamicin and cefotaxime
B) Ampicillin, gentamicin, and cefotaxime
C) Ampicillin and gentamicin
D) Cephalexin and tobramycin
, E) Penicillin G and chloramphenicol
CORRECT ANSWER: C) Ampicillin and gentamicin
RATIONALE: Ampicillin and gentamicin represent first-line empiric therapy for early-
onset sepsis in neonates. Ampicillin covers Group B Streptococcus and Listeria
monocytogenes (gram-positive organisms), while gentamicin covers aerobic gram-
negative organisms including E. coli. This combination provides synergistic coverage
for most organisms causing early-onset neonatal sepsis. Cefotaxime is added for
late-onset sepsis or when meningitis is suspected. Chloramphenicol has fallen out
of favor due to toxicity. Cephalosporins alone are inadequate for initial empiric
coverage.
6. A neonate is receiving indomethacin for patent ductus arteriosus closure.
Which laboratory value requires closest monitoring?
A) Serum glucose
B) Serum creatinine and urine output
C) Hemoglobin level
D) Platelet count only
E) Liver enzymes exclusively
CORRECT ANSWER: B) Serum creatinine and urine output
RATIONALE: Indomethacin, a nonsteroidal anti-inflammatory drug used for PDA
closure, significantly reduces renal perfusion through inhibition of renal
prostaglandin synthesis. This can precipitate acute kidney injury, manifesting as
elevated creatinine and decreased urine output. Close monitoring of renal function
(creatinine, BUN, urine output) is essential before each dose. While platelet count
can decrease and GI bleeding may occur, renal complications are the most clinically
significant adverse effect requiring intensive monitoring during indomethacin
therapy.
